Discovery Biotech

A mission to deliver high-impact drug inventions ready for clinical trials. Our first products provide extremely effective solutions to combat cancer Startups and research institutes develop more than 50% of new drug approvals before they enter clinical trials. However, many high-impact drug therapy candidates never reach the market or clinical trials in traditional academic research settings. Valuable inventions are locked away in academia for many reasons, such as insufficient funding, limited internal development resources, and a lack of trusted partnerships in the pharmaceutical industry. Discovery Biotech is uniquely positioned to bridge the academic and pharmaceutical ecosystems. We provide researchers and institutions with a deterministic path from invention to marketable drug therapy.